4
Changes in Ownership
ACADIA PHARMACEUTICALS INC Filed Acc 0001209191-19-049230
Director sold 30,000 shares at an average $37.80 ($1,133,860)
- Director acquired 30,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Daly James M Director | 2019-09-09 | Option exercise | +30,000 | $17.52 | $525,600 | 30,000 | D |
| Daly James M Director | 2019-09-09 | Sale | −29,600 | $37.79 | $1,118,504 | 400 | D |
| Daly James M Director | 2019-09-09 | Sale | −400 | $38.39 | $15,356 | 0 | D |
| Derivatives | |||||||
| Daly James M Director | 2019-09-09 | Option exercise · Stock Option (Right to Buy) | −30,000 | 0 | D | ||
| Open-market sales · 30,000 sh · avg $37.80 · $1,133,860 | |||||||
Loading xslF345X03/doc4.xml…